RPS18P12

Across TCGA pan-cancer cohorts, RPS18P12 RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated RPS18P12 data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher RPS18P12 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RPS18P12 expression acts as an unfavorable survival marker, although some lineages such as CESC and LUSC show a favorable association.

ACC, CESC, and LUSC are the cancer types where RPS18P12 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	DFS	Median	All	0.240	0.649	<.001	68	view →
CESC	DFS	Median	II,III,IV	0.738	0.279	<.001	64	view →
LUSC	OS	Tertile	All	0.493	0.309	<.001	44	view →
SARC	DFS	Quartile	All	0.483	0.698	<.001	31	view →
LIHC	OS	Quartile	All	0.683	0.888	.002	31	view →
KIRP	OS	Quartile	All	0.864	0.970	.005	25	view →
READ	DFS	Median	All	0.925	0.670	.004	25	view →
KICH	DFS	Quartile	II,III,IV	0.457	1.000	.012	22	view →
COAD	DFS	Tertile	All	0.832	0.486	.002	19	view →
KIRC	DFS	Tertile	III,IV	0.754	0.550	.014	14	view →
SKCM	OS	Tertile	III,IV	0.894	0.752	.003	13	view →
THYM	DFS	Quartile	All	0.910	0.677	.012	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 21 lineages.

RPS18P12–ACC (DFS)

Open the ACC breakdown →